Sort
38,696 grants matching “als”
Neuroprotective role of GLP-1 receptor agonists
$981,407Nigel H. Greig · National Institute On Aging · ZIA · FY2017 · AG
The role of autophagy in aging and metabolism
$980,719Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Host Immune Responses to Antigens of Malaria Parasites
$980,178Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Immunology of aging and immunotherapy of aging-associated diseases
$979,308Arya Biragyn · National Institute On Aging · ZIA · FY2023 · AG
Protein Modifications Involved in Cell Signaling
$979,268Aleksandra Nita-Lazar · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Capacity Enhancement Core
$978,952Patricia Chamberlain · Oregon Social Learning Center, Inc. · P30 · FY2009 · DA
Biological Information Technology & Systems - BITS: Epigenetic Computers: An in vitro, in abstractio, and in silico Study
$977,930Kwabena A Boahen · University Of Pennsylvania · · FY2001 · CSE
Impact of RNA binding proteins on translation initiation and elongation.
$977,822Markus Hafner · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
Immunology of aging and immunotherapy of aging-associated diseases
$977,820Bira Arya · National Institute On Aging · ZIA · FY2015 · AG
Ion Channel Regulation By Signal Transduction Pathways
$977,352David Armstrong · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Spasticity and Upper Motor Neuron Disorders
$977,309Mary Kay Floeter · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Functional and mechanistic studies of human-specific long noncoding RNAs using a humanized mouse model
$977,162Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Molecular Basis of Obesity and Obesity-induced Metabolic Diseases
$977,162Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$976,871Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Low cost molecular assay for HIV
$976,790Bertrand Lemieux · Biohelix Corporation · R44 · FY2010 · AI
DEVELOPMENT OF A PATIENT-FRIENDLY FORMULATION OF EDARAVONE FOR THE TREATMENT OF ALS
$976,790Treeway B.V. · · FY2017 · Department of the Army
A digital tool for monitoring speech decline in ALS
$976,474Jordan R Green · Modality.Ai , Inc · R42 · FY2024 · DC
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates
$976,445Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2024 · AI
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies
$976,015Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Development of a Technology Platform for Engineering Single-Administration HIV Therapeutics
$975,928Leor S Weinberger · J. David Gladstone Institutes · R56 · FY2019 · AI
Clinical readiness of Uzap - the minimally invasive Overactive Bladder treatment
$975,754Roger Stern · Stellartech Research Corporation · R44 · FY2023 · DK
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders
$975,562John M Littleton · Naprogenix, Inc · R44 · FY2021 · AA
The Laboratory of Stem Cell Biology
$975,474Mahendra Rao · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2012 · AR
LIGHT-ACTIVATED GENE EXPRESSION IN SINGLE CELLS (RMI)
$975,000Albert Einstein Col Of Med Yeshiva Univ · P20 · FY2004 · EB
ENABLING WIDESPREAD, MINIMALLY INVASIVE DISTRIBUTION OF MULTIMODAL THERAPEUTIC HNSCS THROUGHOUT THE NEUROAXIS OF ALS MICE
$974,999Sanford Burnham Prebys Medical Discovery Institute · · FY2016 · Department of Defense